KLK3 and prostate carcinoma: Some of the markers used vary in different types of cancer, for example cytokeratins apply to breast, colon and prostate cancers, and other epithelial tumors, although specific tissue antigens can also be used, such as prostate specific antigen (PSA) or breast specific mammaglobin [17].